Maltz Prize for Outstanding Achievement in Schizophrenia Research

Maltz Prize for Outstanding Achievement in Schizophrenia Research

Established in 2005, the prize was renamed in 2016 in honor of Board Members Milton and Tamar Maltz. The Maltz Prize provides $40,000 to an investigator who has undertaken innovative and promising research in schizophrenia. Winners of this prize are selected by the Lieber Prize recipient(s) of the same year.

2017 Prizewinners

William P. Horan, Ph.D.

Research Psychologist

Dr. Horan conducts translational research to identify factors that contribute to difficulties in community integration among people with schizophrenia and other forms of psychosis, and has been a leader in the development of innovative treatments that may help patients improve the quality of their lives. More recently, he has begun applying this translational research approach to investigations of bipolar disorder and homelessness. In addition, he has focused on the development and validation of the Social Cognitive Skills Training Program for people with psychosis. The goal of this research is to develop new treatments that enable people with psychosis to live independently, pursue personally meaningful vocational and educational goals, and develop more satisfying social networks in the community. His work has led to a deeper understanding of the impairments in motivation and social behaviors that affect the lives of many people with schizophrenia, previously viewed by most clinicians as untreatable, and led to a new sense of optimism that these problems can be addressed in the clinic.

Prizewinner Video:

Amanda McCleery, Ph.D.

Assistant Research Psychologist

Dr. McCleery’s research focuses on cognitive predictors of functional outcome in schizophrenia and related conditions. Her recent work uses EEG techniques in conjunction with performance-based measures to better understand the nature of the relationships between early-stage information processing, higher-order cognition, and community functioning across phases of illness in schizophrenia. Her work is also informed by developmental psychopathology in order to gain a nuanced understanding of the trajectory of cognition over the course of illness to identify potential critical periods and targets for intervention, as well as possible mechanisms of change.